当前位置:首页 - 行情中心 - 百诚医药(301096) - 财务分析 - 现金流量表

百诚医药

(301096)

  

流通市值:45.11亿  总市值:59.52亿
流通股本:8278.72万   总股本:1.09亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金237,057,558.97197,166,542.198,676,390.84575,158,616.73
  收到的税费返还---33,229,411.92
  收到其他与经营活动有关的现金16,775,420.5214,363,165.1110,048,757.2543,651,765.28
  经营活动现金流入小计253,832,979.49211,529,707.21108,725,148.09652,039,793.93
  购买商品、接受劳务支付的现金173,731,984.45107,851,623.4755,829,619.42316,569,736.04
  支付给职工以及为职工支付的现金210,960,922.9150,080,765.7184,350,187.6342,685,045.7
  支付的各项税费10,504,504.019,644,269.859,237,777.6627,972,057.97
  支付其他与经营活动有关的现金38,421,185.3558,372,287.2329,337,444.61160,669,879.86
  经营活动现金流出小计433,618,596.71325,948,946.26178,755,029.29847,896,719.57
  经营活动产生的现金流量净额-179,785,617.22-114,419,239.05-70,029,881.2-195,856,925.64
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额289,098.8616,287.1516,287.15-
  收到的其他与投资活动有关的现金308,244,674.62238,624,269.71128,015,986.27472,533,753.97
  投资活动现金流入小计308,533,773.48238,640,556.86128,032,273.42472,533,753.97
  购建固定资产、无形资产和其他长期资产支付的现金84,160,403.3858,497,334.0940,593,856.89395,104,433.86
  投资支付的现金16,634,377.426,650,0005,000,00061,116,000
  取得子公司及其他营业单位支付的现金---13,426,477.17
  支付其他与投资活动有关的现金396,221,684309,666,134.38171,224,321.73467,424,302.69
  投资活动现金流出小计497,016,464.8374,813,468.47216,818,178.62937,071,213.72
  投资活动产生的现金流量净额-188,482,691.32-136,172,911.61-88,785,905.2-464,537,459.75
三、筹资活动产生的现金流量:
  吸收投资收到的现金---9,383,342.98
  其中:子公司吸收少数股东投资收到的现金---490,000
  取得借款收到的现金816,782,342.6510,000,000200,000,0001,244,337,320
  筹资活动现金流入小计816,782,342.6510,000,000200,000,0001,253,720,662.98
  偿还债务支付的现金491,582,342.6266,400,00080,000,000905,500,000
  分配股利、利润或偿付利息支付的现金15,768,956.19,462,858.544,240,761.0948,771,181.15
  支付其他与筹资活动有关的现金524,223.68231,335.24105,086.821,359,430.34
  筹资活动现金流出小计507,875,522.38276,094,193.7884,345,847.91955,630,611.49
  筹资活动产生的现金流量净额308,906,820.22233,905,806.22115,654,152.09298,090,051.49
四、汇率变动对现金及现金等价物的影响312,756.01326,514.9-30,408.9112,965.02
五、现金及现金等价物净增加额-59,048,732.31-16,359,829.54-43,192,043.22-362,291,368.88
  加:期初现金及现金等价物余额416,161,346.06416,161,346.06416,161,346.06778,452,714.94
  期末现金及现金等价物余额357,112,613.75399,801,516.52372,969,302.84416,161,346.06
补充资料:
  净利润-3,098,160.54--52,922,991.09
  资产减值准备-6,728,581.21-41,000,148.95
  固定资产和投资性房地产折旧-77,147,845.07-141,830,582.73
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-77,147,845.07-141,830,582.73
  无形资产摊销-1,833,568.4-3,480,557.58
  长期待摊费用摊销-294,791.88-357,178.23
  固定资产报废损失---9,875.23
  财务费用-9,673,278.07-17,040,096.57
  投资损失--1,688,430.57-5,591,708.21
  递延所得税-802,123.12-12,876,726.84
  其中:递延所得税资产减少-802,123.12-12,876,726.84
  存货的减少--28,470,143.12--88,198,739.9
  经营性应收项目的减少--161,045,313.25--252,405,023.4
  经营性应付项目的增加--23,135,554.11-3,261,281.03
  其他----28,268,035.19
  现金的期末余额-399,801,516.52-416,161,346.06
  减:现金的期初余额-416,161,346.06-778,452,714.94
  现金及现金等价物的净增加额--16,359,829.54--362,291,368.88
公告日期2025-10-252025-08-272025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑